IDEX Corporation (IEX)
Reasons Why Investors Should Consider Investing in IDEX Stock
IEX is gaining from strong HST demand, rising orders, acquisitions and shareholder returns as it lifts its 2026 organic sales growth outlook.
Is IDEX (IEX) Stock Outpacing Its Industrial Products Peers This Year?
Here is how Idex (IEX) and Murata Manufacturing Inc. (MRAAY) have performed compared to their sector so far this year.
Here's Why You Should Consider Investing in IDEX Stock Now
IEX is gaining from strong data center, semiconductor, space and defense demand, acquisitions and shareholder returns.
Why Is Idex (IEX) Up 0.1% Since Last Earnings Report?
Idex (IEX) reported earnings 30 days ago. What's next for the stock?
Idex (IEX) Upgraded to Buy: Here's Why
Idex (IEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are You Looking for a Top Momentum Pick? Why Idex (IEX) is a Great Choice
Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.
IDEX Q2 Earnings Call Highlights
IDEX NYSE: IEX reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.
IDEX Beats Q2 Earnings Estimates on HST Momentum, Raises View
IEX tops second-quarter estimates, posts record orders above $1 billion and raises its 2026 outlook as demand improved across key end markets.
Compared to Estimates, Idex (IEX) Q2 Earnings: A Look at Key Metrics
The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Idex (IEX) Q2 Earnings and Revenues Top Estimates
Idex (IEX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $2.07 per share a year ago.
IDEX Gears Up to Report Q2 Earnings: What's in the Cards?
IEX reports Q2 results on July 29, with revenue growth expected as Health & Science demand and acquisitions support sales despite cost pressures.
Idex (IEX) Earnings Expected to Grow: Should You Buy?
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
